MED 27, with the CAS number 104333-87-1, is a chemical compound that belongs to the class of compounds known as benzamides. It is primarily recognized for its potential applications in medicinal chemistry, particularly in the development of pharmaceuticals. MED 27 exhibits properties that may influence various biological pathways, making it a subject of interest in research related to neuropharmacology and other therapeutic areas. The compound's structure typically includes a benzene ring substituted with an amide group, which contributes to its chemical reactivity and biological activity. As with many compounds in drug development, its efficacy and safety profile would be evaluated through preclinical and clinical studies. Additionally, the compound's solubility, stability, and interaction with biological targets are critical factors that determine its potential as a therapeutic agent. However, specific details regarding its pharmacokinetics, mechanism of action, and therapeutic uses would require further investigation and are often proprietary to the research entities involved.

MED 27

104333-87-1: MED 27, with the CAS number 104333-87-1, is a chemical compound that belongs to the class of compounds known as benzamides. It is primarily recognized for its potential applications in medicinal chemistry, particularly in the development of pharmaceuticals. MED 27 exhibits properties that may influence various biological pathways, making it a subject of interest in research related to neuropharmacology and other therapeutic areas. The compound's structure typically includes a benzene ring substituted with an amide group, which contributes to its chemical reactivity and biological activity. As with many compounds in drug development, its efficacy and safety profile would be evaluated through preclinical and clinical studies. Additionally, the compound's solubility, stability, and interaction with biological targets are critical factors that determine its potential as a therapeutic agent. However, specific details regarding its pharmacokinetics, mechanism of action, and therapeutic uses would require further investigation and are often proprietary to the research entities involved.

<p>MED 27 is an inhibitor of thromboxane synthase and thromboxane A2 receptors. It effectively inhibits rat platelet aggregation at doses significantly lower than those required for acetylsalicylic acid.</p>

CAS 104333-87-1

MED 27

MED 27

Ref: TM-T207505